GSK, Novartis get ACCC okay to restructure

The Australian Competition and Consumer Commission says it won’t oppose GlaxoSmithKline’s and Novartis’ transactions involving over-the-counter consumer products, human vaccines and oncology products. As a result of the transactions: GSK will acquire Novartis' global human vaccines business, except the influenza vaccines business; GSK and Novartis will combine their global consumer health business in a new

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Family key in glaucoma risk
Next Expert review wants CMs feedback